HILLEVAX INC's ticker is and the CUSIP is 43157M102. A total of 69 filers reported holding HILLEVAX INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,260 | -21.4% | 1,431,968 | +0.5% | 0.01% | -17.6% |
| Q2 2023 | $24,495 | +22.3% | 1,424,935 | +17.6% | 0.02% | +21.4% |
| Q1 2023 | $20,026 | -1.2% | 1,211,492 | +0.0% | 0.01% | -12.5% |
| Q4 2022 | $20,266 | -99.9% | 1,211,322 | +10.1% | 0.02% | +6.7% |
| Q3 2022 | $18,799,000 | – | 1,100,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 558,923 | $9,350,782 | 12.37% |
| Frazier Life Sciences Management, L.P. | 9,758,359 | $163,257,346 | 10.15% |
| Abingworth LLP | 1,838,486 | $30,757,871 | 10.02% |
| Samsara BioCapital, LLC | 610,062 | $10,206,337 | 2.20% |
| StepStone Group LP | 676,567 | $11,318,966 | 1.48% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,694,101 | $45,072,310 | 0.93% |
| BRAIDWELL LP | 1,620,216 | $27,106,214 | 0.91% |
| RA Capital Management | 1,760,019 | $29,445,118 | 0.60% |
| Perceptive Advisors | 406,024 | $6,792,782 | 0.19% |
| BVF INC/IL | 248,579 | $4,158,727 | 0.18% |